Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$265,285,749
New position
Shares Held
1,345,126
first reported quarter
Ownership
0.087%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Korea Investment CORP holds $2,395,402,868 across 10 Drug Manufacturers - General names. AZN ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
711,353 | $654,281,148 | |
| 2 | JNJ |
Johnson & Johnson
|
1,977,874 | $483,471,520 | |
| 3 | ABBV |
AbbVie Inc.
|
1,267,180 | $275,598,978 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
1,345,126 | $265,285,749 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,897,151 | $228,208,293 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,132,515 | $157,838,615 | |
| 7 | AMGN |
Amgen Inc
|
395,932 | $139,308,674 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,703,989 | $103,346,932 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $265,285,749 | 1,345,126 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||